Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	8.16	81.64	75.48
Graham Fair Price	2.20	30.87	30.21
PEG	3008.50	23.29	0.75
Price/Book	10.14	6.38	5.79
Price/Cash Flow	-93.36	102.13	1537.17
Prices/Earnings	11.33	33.04	29.68
Price/Sales	11.40	8.07	7.25
Price/FCF	-93.36	102.13	1537.17
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	6.89	0.17	0.16
Operating Margin	3.97	0.09	0.09
ROA	-1.03	0.02	0.02
ROE	0.05	0.05	-1.07
ROIC	0.03	0.03	5.00
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	0.06	-87.78
Dividends QOQ	< 0.005	< 0.005	-14.06
EBIT QOQ	0.03	0.06	72.30
EPS QOQ	0.40	0.01	-96.42
FCF QOQ	-0.95	16.09	1595.61
Revenue QOQ	-0.03	0.02	-25.91
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	< 0.005	-0.61
Days Sales Outstanding (DSO)	82.77	82.04	-0.88
Inventory Turnover	1037769000.00	1044121000.00	0.61
Debt/Capitalization	0.43	0.39	-8.52
Quick Ratio	1.14	1.13	-1.08
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	28.84	29.63	2.75
Cash	3.73	3.93	5.51
Capex	-0.06	-0.07	-15.58
Free Cash Flow	0.11	1.85	1603.27
Revenue	23.04	23.40	1.58
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.25	1.24	-1.03
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.31	7.02	-3.92
Naive Interpretation	Member

06 - Financial Health · Weak

Rating